This Week’s Biopharma News: Amgen Deepens US Manufacturing Push
The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production
False
The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
False
False
November 18, 2026
2 min read
Researchers combine stem cell differentiation and optimized culture conditions to recreate key features of the human crystalline lens
November 16, 2026
2 min read
Vector DNA integration was identified near or within the GLI1 oncogene in tumors from two treated patients
November 13, 2026
1 min read
Fujifilm Cellular Dynamics’ Delara Motlagh discusses her path into cell and gene therapy, the challenges of scaling manufacturing, and the potential of iPSC technologies
November 11, 2026
2 min read
Replacing guidance from 2011, the FDA's updated framework emphasizes potency assurance throughout cell and gene therapy development and manufacturing
False
Affiliations:
Specialties:
Areas of Expertise: